论文部分内容阅读
目的:探讨咳喘灵合剂在AECOPD患者中的治疗应用效果。方法:AECOPD患者120例根据治疗方法的不同分为治疗组与对照组各60例,对照组采用传统药物治疗,治疗组在此基础上加用咳喘灵合剂进行治疗。结果:治疗后2组的总有效率分别为95.0%和93.3%,组间对比差异无统计学意义(P>0.05)。治疗组的咳嗽、发热、痰鸣等症状消失时间明显低于对照组(P<0.05)。结论:咳喘灵合剂在AECOPD患者中能更快的缓解临床症状,值得进一步临床推广应用。
Objective: To investigate the therapeutic effect of Kechuanling agent in AECOPD patients. Methods: 120 cases of AECOPD patients were divided into treatment group and control group of 60 cases according to the different treatment methods. The control group was treated with traditional medicine. The treatment group was treated with Kechuanling agent. Results: The total effective rates of the two groups after treatment were 95.0% and 93.3% respectively. There was no significant difference between the two groups (P> 0.05). Treatment group cough, fever, phlegm and other symptoms disappeared significantly lower than the control group (P <0.05). Conclusion: Kechuanling agent can relieve clinical symptoms more quickly in patients with AECOPD, which deserves further clinical application.